Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sirote Khunapornphairote"'
Autor:
Sinee Disthabanchong, Sarunya Saeseow, Sirote Khunapornphairote, Ronnarat Suvikapakornkul, Yodying Wasutit, Jumroon Tungkeeratichai
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Aims/IntroductionParathyroidectomy is associated with improved survival in patients with end-stage kidney disease. Protein-energy wasting (PEW) is common in patients with kidney failure and predicts poor outcomes. Recent clinical trials have linked h
Externí odkaz:
https://doaj.org/article/e10eef389b484be784a6c247d66057e0
Autor:
Sinee Disthabanchong, Kornpong Vantanasiri, Sirote Khunapornphairote, Payupol Chansomboon, Nuchcha Buachum, Sarunya Saeseow
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
Severe hyperparathyroidism predicts poor outcomes in patients with kidney failure. Mechanisms underlying the relationship between high parathyroid hormone (PTH) and decreased survival other than bone loss are largely unexplored. Recent evidence sugge
Externí odkaz:
https://doaj.org/article/483eeffc17f0481c9f27543c2680f429
Autor:
Manoon Surabotsophon, Yingyot Klai‐On, Vipa Thanachartwet, Sirote Khunapornphairote, Supat Chamnanchanunt, Theerapat Racharak, Wannada Laisuan, Duangjai Sahassananda, Samlee Hapunna, Somjit Jinapuk, Suthee Leelasetakul, Varunee Desakorn
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 3263-3276 (2020)
Abstract Three patients diagnosed with severe COVID‐19 pneumonia received treatment with hydroxychloroquine combined with lopinavir, ritonavir, and favipiravir. Two patients diagnosed early, received tocilizumab when the pneumonia became severe and
Externí odkaz:
https://doaj.org/article/3e36fc9f2ed64a68ba1892234398a172
Autor:
Yingyot Klai-On, Samlee Hapunna, Vipa Thanachartwet, Manoon Surabotsophon, Sirote Khunapornphairote, Varunee Desakorn, Theerapat Racharak, Wannada Laisuan, Supat Chamnanchanunt, Somjit Jinapuk, Duangjai Sahassananda, Suthee Leelasetakul
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 8, Iss 12, Pp 3263-3276 (2020)
Clinical Case Reports, Vol 8, Iss 12, Pp 3263-3276 (2020)
Three patients diagnosed with severe COVID‐19 pneumonia received treatment with hydroxychloroquine combined with lopinavir, ritonavir, and favipiravir. Two patients diagnosed early, received tocilizumab when the pneumonia became severe and survived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef59c350665c9270f7e9bf93c2e59853
http://europepmc.org/articles/PMC7675634
http://europepmc.org/articles/PMC7675634
Autor:
Duangjai Sahassananda, Theerapat Racharak, Supat Chamnanchanunt, Manoon Surabotsophon, Suthee Leelasetakul, Wannada Laisuan, Vipa Thanachartwet, Sirote Khunapornphairote, Samlee Hapunna, Yingyot Klai-On, Somjit Jinapuk, Varunee Desakorn
Three patients with COVID-19 pneumonia received treatment with hydroxychloroquine combined with lopinavir plus ritonavir and favipiravir. Two patients early diagnosed with COVID-19 pneumonia received tocilizumab at severe pneumonia diagnosed and surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b48c1b859a909efa7012f272a99e5b33
https://doi.org/10.22541/au.159527014.49016403
https://doi.org/10.22541/au.159527014.49016403
